Navigation Links
Omeros Names Dr. Patrick Gray as Scientific Fellow
Date:3/27/2012

SEATTLE, March 27, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced the appointment of Patrick W. Gray, Ph.D. to the position of scientific fellow.

"Pat has an impressive track record of identifying commercially successful programs and products early in their development cycle," said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros.  "In his role as scientific fellow, Pat will be able to leverage his unique and deep expertise across our research and development matrix.  We are pleased that he has joined our senior management team, and we look forward to him contributing to our success."

"The scientific depth and commercial potential of Omeros' programs are remarkable," stated Patrick W. Gray, Ph.D., Omeros' scientific fellow.  "Omeros has a strong and experienced management team, and I look forward to helping the Company continue to transform its pipeline of programs into marketed products."

Dr. Gray brings to Omeros more than 30 years of experience in the biotechnology industry. He joined Omeros after serving from 2007 until 2012 as the chief scientific officer of Accelerator Corporation, a biotechnology-company investor and incubator affiliated with Amgen Ventures, ARCH Venture Partners, OVP Ventures Partners and the Institute for Systems Biology. Prior to Accelerator, Dr. Gray was the chief executive officer of nura, inc., a privately held biotechnology company acquired by Omeros in 2006. Before nura, he held senior scientific and management positions at Genentech, Inc., ICOS Corporation and MacroGenics, Inc.

Dr. Gray's career accomplishments include the first cloning and characterization of
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros to Present at the Cowen and Company 32nd Annual Health Care Conference
2. BioMed Realty and Omeros Sign New 64,500 Square Foot Lease in Seattle
3. Omeros Announces Submission to European Medicines Agency of Paediatric Investigation Plan Letter of Intent for OMS302
4. Omeros to Present at 23rd Annual Piper Jaffray Health Care Conference
5. Omeros Announces First Patients Treated in Phase 3 Clinical Program Evaluating OMS302
6. Omeros Unlocks Four Additional Orphan GPCRs
7. Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders
8. Omeros Reports Allowance of Additional Patent for Arthroscopic Product
9. Omeros Announces Clinical Development Programs for OMS103HP and OMS302
10. Omeros Corporation Reports First Quarter 2011 Financial Results
11. Omeros Announces Expansion of Potential Indications for PDE7 Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Germany , and MARSEILLE, ... , Exclusive global license from University ... mutations, including next-generation sequencing (NGS) gene panels, for blood ... targeted by new test, indicate favorable prognosis for patients ... QIAGEN sees potential for developing companion diagnostics to ...
(Date:7/24/2014)... July 24, 2014  IRIDEX Corporation (NASDAQ: ... second quarter 2014 financial results after the market closes ... with the release, the Company will host a conference ... Eastern Time on Thursday, July 31, 2014 ... other business developments. Interested parties may access ...
(Date:7/24/2014)... 24, 2014  IGI Laboratories, Inc. (NYSE MKT: IG), a ... announced its financial results for the second quarter ended June ... , Total revenues of $6.5 million in the second quarter ... in 2013 , Total revenues of $13.3 million for ... 78% over the same period in 2013 , Total ...
Breaking Medicine Technology:QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7
... New "Oxygen Sandwich" Device is First to Mimic Natural ... the major challenges to islet,cell transplantation as the treatment ... donor tissue supply. Patients often need a re-infusion of ... donor pancreas is,needed to provide the fragile islet cells ...
... Ozarelix Was Maintained For ... Up To Six Months, ... IRVINE, Calif., Sept. 5 Spectrum,Pharmaceuticals, Inc., (Nasdaq: SPPI ) ... drug candidate for the,treatment of benign prostatic hypertrophy (BPH), at the 29th ...
Cached Medicine Technology:Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells 2Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 2Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 3Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 4Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie 5
(Date:7/25/2014)... July 25, 2014 Ticket Down ... the board for the Guinness International Champions Cup match ... FC at Soldier Field on Sunday, July 27th. ... customer appreciation promo/coupon/offer code SOCCER-2014 for added savings. , ... for diehard soccer fans in North America. Countless international ...
(Date:7/25/2014)... The Gerontological Society of America (GSA) ... field of aging has chosen Heather M. ... California, Davis, as the 2014 recipient of the ... distinguished honor, presented by GSA,s Health Sciences Section, ... in recognition of outstanding and sustained contribution to ...
(Date:7/25/2014)... Reproductive Science Center (RSC) of New ... Luzzo, Lead Physician at RSC Rhode Island, received the ... in fertility care and community outreach issued by Providence ... PBN Awards ceremony held July 24th at Salve Regina ... highly regarded, emerging leaders in their field were recognized ...
(Date:7/25/2014)... Houston, TX (PRWEB) July 25, 2014 ... Annual Family Fun Fest on Sunday, July 27 at ... franchises include Memorial, Copperfield, Katy, Pearland, Friendswood, Spring, ... location in The Heights. , “We’re thrilled to ... this year,” said Heather Belcher who owns the Sugarland-Missouri ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 AttorneyOne.com, a recognized ... latest information from the FDA on Ibuprofen and Oxcarbazepine ... that one lot of Ibuprofen and one lot of Oxcarbazepine ... due to mislabeled packaging. Oxcarbazepine is used for the treatment ... , The reason for the recall is that Lot ...
Breaking Medicine News(10 mins):Health News:Liverpool FC vs. Olympiacos FC Tickets Soldier Field: Ticket Down Slashes Ticket Prices for Guinness International Champions Cup in Chicago on Sunday, July 27th 2Health News:Young earns GSA's 2014 Doris Schwartz Gerontological Nursing Research Award 2Health News:Dr. Kerri Luzzo of the Reproductive Science Center of Providence Receives “40 Under Forty Award" for Outstanding Professional Accomplishments and Community Outreach 2Health News:The Little Gym of Houston to Attend Houston Family Magazine’s Family Fun Fest 2014 2Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2
... Effect Sept. 11; Online Resources and Helpline Now,Available, ... date of Pennsylvania,s Clean Indoor Air Act fast approaching, ... to help,them comply with the law that will ban ... portion of casino floors., Guidance and a downloadable ...
... MBF Healthcare,Acquisition Corp. (Amex: MBH ), ... today the amendment of the Stock Purchase,Agreement ... Solutions,Holdings, Inc. ("CHS"), based on the signed ... (the "Stock Purchase Agreement"). CHS is a,privately-owned, ...
... 2 Ethiopia,s Ministry of Health,recently signed a ... at helping the country reach the U.N.,s Millennium,Development ... do so., The agreement provides a framework ... Ethiopia and the partners who are,contributing to the ...
... even a year after routine was stopped, study says ... may help treat memory problems in adults, according to ... 138 people age 50 and older at increased risk ... led to modest improvements in cognitive function in adults ...
... benefit of nation,s 1st such law, passed in 2004 , , ... ill kids have made use of California,s pioneering paid family ... it exists, according to researchers at the Rand Corp. ... law. It is funded by employees through an automatic payroll ...
... Normal Weight Obesity: A Real Health Risk, ... are,highlights from the September issue of Mayo ... as often as you wish. Mayo Clinic ... for a fee.,Include the following subscription information ...
Cached Medicine News:Health News:PA Department of Health Reminds Businesses to Prepare to Implement Clean Indoor Air Act 2Health News:MBF Healthcare Acquisition Corp. Amends Stock Purchase Agreement With Critical Homecare Solutions Holdings, Inc. to Extend Termination Date to October 31, 2008 2Health News:MBF Healthcare Acquisition Corp. Amends Stock Purchase Agreement With Critical Homecare Solutions Holdings, Inc. to Extend Termination Date to October 31, 2008 3Health News:MBF Healthcare Acquisition Corp. Amends Stock Purchase Agreement With Critical Homecare Solutions Holdings, Inc. to Extend Termination Date to October 31, 2008 4Health News:Ethiopia First Nation to Sign National Health Partnership Compact 2Health News:Exercise May Help Prevent Age-Related Memory Loss 2Health News:Paid Family Leave Program Goes Mostly Unused 2Health News:September 2008 Mayo Clinic Women's HealthSource Highlights Normal Weight Obesity, Regular Exercise and Cholesterol 2Health News:September 2008 Mayo Clinic Women's HealthSource Highlights Normal Weight Obesity, Regular Exercise and Cholesterol 3Health News:September 2008 Mayo Clinic Women's HealthSource Highlights Normal Weight Obesity, Regular Exercise and Cholesterol 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: